The economics of selective serotonin reuptake inhibitors in depression: A critical review

The prevalence of depression and the high costs associated with its treatment have increased interest in pharmacoeconomic evaluations of drug treatment, particularly in the 1990s as the use of selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors (SSRIs) expanded substantially. This re...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	CNS drugs 2001, Vol.15 (1), p.59-83
Hauptverfasser:	FRANK, Lori, REVICKI, Dennis A, SORENSEN, Sonja V, SHIH, Ya-Chen Tina
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Clinical Trials as Topic - economics Clinical Trials as Topic - statistics & numerical data Decision Support Techniques Depression - drug therapy Depression - economics Economics, Pharmaceutical Humans Medical sciences Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Pharmacology. Drug treatments Serotonin Uptake Inhibitors - economics Serotonin Uptake Inhibitors - therapeutic use Serotoninergic system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!